If cancer has affected members of your family, you may already be thinking about prevention. Genetics play a role, but family history doesn’t determine destiny. The miRoncol Real-time Multi-Cancer Early Risk Assessment provides current biological insight that goes beyond inherited predisposition, giving you and your physician a clearer picture of your health today.
The miRoncol test measures microRNA patterns in blood sensitive signals linked to early tumour biology. This provides:
This is an early risk assessment, not a diagnostic tool. It does not replace genetic counselling or physician-led screening but is designed to complement them by adding real-time molecular context.
If cancer runs in your family, you can take proactive steps today. The miRoncol Real-time Multi-Cancer Early Risk Assessment helps you see what’s happening inside your body now supporting earlier, more informed discussions with your physician.